menopausal symptoms. Other obstetric conditions, not elsewhere classified
Conditions
Interventions
Intervention 1: First group will be given Tab Vitagnus oral, 2 times daily for 8 weeks. Intervention 2: Second group will be given Tab Calci Soya Balance oral, 1 time daily for 8 weeks.
Treatment - Drugs
First group will be given Tab Vitagnus oral, 2 times daily for 8 weeks.
Second group will be given Tab Calci Soya Balance oral, 1 time daily for 8 weeks.
Sponsors
Research deputy of Tehran University of Medical sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria:menopause women with at least one year after amenorrhea history; that suffer of menopausal symptoms. Exclusion criteria:have history of Brest cancer; take Tamokcifen;take chemotropic;have malignancy; have active hepatic or renal disease; take HRT or other menopausal treatments; take progesterone or androgen.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menopausal symptoms. Timepoint: before intervention- 4 weeks later- 8 weeks later. Method of measurement: Kupperman menopausal index. | — |
Secondary
| Measure | Time frame |
|---|---|
| Itch, nausea, diarrhea. Timepoint: End of every week by calling. Method of measurement: by answering to our questions in phone. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahin Bazzazian
Nursing and Midwifery Faculty of Tehran University of Medical sciences
Outcome results
None listed